Eloxx Pharmaceuticals Inc is a United States-based clinical-stage pharmaceutical company. It is focused on building and developing a portfolio of therapeutics for the treatment of cancer and immunological diseases.
$0.29
As of 05/18/2022 IEX book CBOE book
2022 © Stock Market MBA, Inc.